Company intelligence / Profile preview

Alpha Net Health Services

Coral Gables, Florida, United Stateszoominfo.com ↗

Ownership: Private
Development stage: Other

Overview

AlphaNet delivers customized health management and integrated support for individuals with Alpha‑1 Antitrypsin Deficiency. Their peer-to-peer model has led to high adherence rates (>90%) for weekly infusions among patients receiving therapies from partner pharmaceutical companies. The organization reports improved quality of life, reduced emergency visits, and fewer unscheduled doctor appointments among its members. Since its founding in 1995, AlphaNet has contributed over $70 million to research through the Alpha‑1 Foundation.

Therapeutic areas: Rare Diseases
Industry: Non-Academic Healthcare

Partnerships

Grifols (Prolastin-C)CSL Behring (Zemaira)Takeda (Aralast and Glassia)

Beyond the preview

Go deeper on Alpha Net Health Services.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Alpha Net Health Services.

Explore the full profile